AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MICRO-X LIMITED Capital/Financing Update 2020

Jan 1, 2020

65388_rns_2020-01-01_99a0eec1-bf5b-418c-90a2-3cf94953bf9d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [159 x 45] intentionally omitted <==

Micro-X Limited, ABN 21 153 273 735

LAPSE OF OPTIONS

Adelaide, Australia, 2 January 2020 : Australian high-tech company Micro-X Ltd (ASX: MX1) ( Micro-X or the Company ) a leader in cold cathode x-ray technology for health and security markets globally, advises that on 31 December 2019, 1,696,555 unlisted options with an exercise price of $0.575 and 3,393,115 unlisted options with an exercise price of $0.625 have lapsed. These options were issued in connection with the Company’s initial public offering on the ASX.

– ENDS –

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for the global health and security markets, based on proprietary cold cathode, carbon nanotube emitter technology. The electronic control of emitters with this technology enables X-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. The Company has its core R&D, engineering and production capability at its facility in Adelaide, Australia.

The Company’s first product, the Carestream DRX Revolution Nano , is an ultra-lightweight digital medical x-ray system for the rapidly expanding mobile x-ray market in hospitals and healthcare. The Carestream DRX Revolution Nano holds 510(k) and CE Mark certifications and is sold commercially in a number of global markets by the Company’s exclusive distributor, Carestream Health, Inc. The Company has a portfolio of innovative products in development, aimed at customer solutions where there is little or no competition. This includes the Mobile Backscatter Imager or MBI which will image Improvised Explosive Devices for airport security, defence and counter-terrorism applications. The MBI is being jointly developed in partnership with Thales, a global supplier of defence and security technology systems, who are providing technical support and $10 million of funding.

CONTACTS

Micro-X Limited	Investor Enquiries
Peter Rowland Managing Director Tel: +61 8 7099 3966 E:[email protected]	David Allen / John Granger Hawkesbury Partners Tel: +61 2 9103 9494 E:[email protected] [email protected]